
Novarad India Private Limited
About Novarad India Private Limited
Data last updated:
Novarad India Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 20 August 2008.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U72300DL2008PTC182233. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.49 Cr. It was led by directors including Nandhini and Thirumazhisai Putthom Badhri Narayanan.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Lower Ground Floor C – 4/5 Safdarjung Development Area, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2019, the company reported a revenue of ₹61,348, a decline of 89% compared to the previous year. For the same year it recorded a net loss of ₹10 Lakh and EBITDA of -₹10 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 69% over three years.
Company details
Contact details
Novarad India Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressLower Ground Floor C – 4/5 Safdarjung Development Area, New Delhi, Delhi, India – 110016
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Novarad India Private Limited
FY 2019 filings availableNovarad India Private Limited reported revenue of ₹61,348 (down 89% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 69% over three years, including a 89% fall in the latest year. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹10 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novarad India Private Limited, buy the company report.
Board of directors of Novarad India Private Limited
Novarad India has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandhini | Director | 27 Mar 2019 | 7 Years 7 Months | As last reported |
| Thirumazhisai Putthom Badhri Narayanan | Director | 19 Aug 2016 | 10 Years 3 Months | As last reported |
| John Emerson Fowler | Director | 20 May 2009 | 17 Years 6 Months | As last reported |
| Timothy Glenn Law | Director | 16 Mar 2009 | 17 Years 8 Months | As last reported |
Peer comparison
Novarad India Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| HMZ Laboratories Private Limited | ₹66,410 (FY 2022) | Gurgaon, Haryana, India | ||||
| Malwa Medineed Private Limited | ₹64,930 (FY 2025) | 26.0% | Indore, Madhya Pradesh, India | |||
| Himzon Healthcare Private Limited | ₹64,760 (FY 2025) | 17.0% | Delhi, India | |||
| Phlebee Healthcare Network Private Limited | ₹63,978 (FY 2021) | Chennai, Tamil Nadu, India | ||||
| Shreesha Trade Experts Private Limited | ₹61,560 (FY 2025) | Mumbai, Maharashtra, India | ||||
| Novarad India Private Limitedthis company | ₹61,348 (FY 2019) | -₹10 Lakh | -89.0% | New Delhi, Delhi, India | ||
| Eden Life Sciences Private Limited | ₹60,600 (FY 2022) | -99.0% | Chennai, Tamil Nadu, India | |||
| Avaskin Design Systems Private Limited | ₹60,180 (FY 2025) | Noida, Uttar Pradesh, India | ||||
| Tacent Healthcare Private Limited | ₹59,870 (FY 2025) | 10.0% | Delhi, India | |||
| Loretta Concepts Private Limited | ₹57,660 (FY 2024) | 114.0% | Coimbatore, Tamil Nadu, India | |||
| Truelyser Biosystems Private Limited | ₹56,656 (FY 2023) | -100.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Novarad India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Novarad India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novarad India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novarad India has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Novarad India Private Limited, buy the company report.
Recent activity
Novarad India Private Limited has 10 board changes on record since 2009: 4 appointments and 6 cessations. The latest: Nandhini was appointed as Director on 27 Mar 2019.
1 earlier event is in the company report.
Frequently asked questions
Novarad India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Novarad India was a private limited company based in New Delhi, Delhi, India. The company worked in medical and laboratory equipment, within the healthcare industry. It was incorporated on 20 August 2008 and is registered under CIN U72300DL2008PTC182233. The company has been struck off by the Registrar of Companies and is no longer operational.
Novarad India had 4 directors:
- Nandhini - Director
- Thirumazhisai Putthom Badhri Narayanan - Director
- John Emerson Fowler - Director
- Timothy Glenn Law - Director
The CIN (Corporate Identification Number) of Novarad India is U72300DL2008PTC182233. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Novarad India is at Lower Ground Floor C – 45 Safdarjung Development Area, New Delhi, Delhi, India – 110016.
Novarad India was incorporated on 20 August 2008. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Novarad India on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Novarad India has 2 GST registrations on record and all of them are cancelled or inactive.
Novarad India operated in the healthcare industry, in the medical and laboratory equipment segment. It worked in this industry before it was struck off.
The peers of Novarad India by revenue are HMZ Laboratories Private Limited, Malwa Medineed Private Limited, Himzon Healthcare Private Limited, Phlebee Healthcare Network Private Limited, Shreesha Trade Experts Private Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment).
Nandhini was appointed as Director on 27 Mar 2019. Girish Chandra Sharma ceased to be Director on 25 Jan 2019. Nidhish Sharma ceased to be Alternate Director on 24 Jan 2019. Novarad India has 10 board changes on record in total.

